Medindia

X

Weikang Bio-Technology Announces Conference Call to Discuss Second Quarter Fiscal 2010 Results

Thursday, August 12, 2010 Corporate News J E 4
Advertisement
HARBIN, China, Aug. 12 WeikangBio-Technology Group Co., Inc. (OTC Bulletin Board: WKBT) ("Weikang" or the"Company"), a leading developer, manufacturer and marketer of TraditionalChinese Medicine (TCM), Western prescription and OTC pharmaceuticals and otherhealth and nutritional products in the People's Republic of China, todayannounced that it will conduct a conference call at 9:00 a.m. Eastern Time onTuesday, August 17, 2010 to discuss the second quarter fiscal 2010 results.

Mr. Ren Hu, Vice President of Finance of Weikang Bio-Technology will beleading the call.

To participate in the live conference call, please dial the followingnumber fifteen minutes prior to the scheduled conference call time:888-482-0024, international callers should dial 617- 801-9702; conferencepasscode is 64593584.

If you are unable to participate in the call at this time, a replay willbe available for 14 days starting on Tuesday, August 17, 2010 at 10:30 a.m.Eastern Time. To access the replay, dial 888-286-8010 and enter the passcode30290121. International callers should dial 617-801-6888 and enter the samepasscode.

This conference call will be broadcast live over the Internet and may beaccessed by clicking on http://weikangbio.com at the investor info page.Please access the link at least fifteen minutes prior to the start of the callto register, download, and install any necessary audio software. For thoseunable to participate during the live broadcast, a 90-day replay will beavailable shortly after the call by accessing the same link.

About Weikang Bio-Technology Group Co., Inc.

Weikang Bio-Technology Group Co., Inc. is principally engaged indeveloping, manufacturing and distributing Traditional Chinese Medicine (TCM),and health and nutritional supplements in China, in compliance with requisiteChinese licenses and approvals. The Company is also expanding its businessscope to develop, manufacture and distribute Chinese herbal extract productsand GMP certified western prescription and OTC pharmaceuticals through itsacquisition of Tianfang. For more information, please visithttp://www.weikangbio.com .For more information, please contact: Company contact: Ren Hu, VP of Finance Weikang Bio-Technology Group Co., Inc. US Tel: +1-201-887-0415 China cell: +86-137-1872-8163 Email: rhu@weikangbio.com Investors Relation contacts: John Marco, Partner, Elite IR Tel: +1-310-819-2948 Email: John.marco@elite-ir.com Leslie J. Richardson, Partner, Elite IR Tel: +852-3183-0283 Email: Leslie.richardson@elite-ir.com

SOURCE Weikang Bio-Technology Group Co., Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Wilhelmina Models, Shape and Men's Fitness Announc...
S
NextWave Pharmaceuticals and Tris Pharma Enter int...